PULM Total Utang marang Modal Pulmatrix Corporation

Lambang korporat lan logo Pulmatrix, Inc. (PULM)

The immediate trigger for Pulmatrix, Inc. (PULM) will be the disclosure of trial results for powder-based agents against pulmonary fungi, while the market capitalization already prices in past failures and liquidity shortages. The company focuses on inhalation therapy, relying on grants and clinical trial success due to a lack of recurring revenue. This price chart on GURU.Markets illustrating trading dynamics shows a debt-to-equity ratio of 0.00, confirming its status as a reputable developer of drug delivery systems.

PULM: Total Utang marang Modal Pulmatrix 04.07.2022 - 28.10.2026

Rincian analitis lan laporan data perusahaan Pulmatrix Corporation (PULM)

- rega lan prakiraan konsensus rega:
Bagan rega Pulmatrix|PULM - Bagan tingkat prakiraan
- data kapitalisasi pasar:
Kapitalisasi pasar Pulmatrix|PULM - Nilai Dipunlarasaken Utang lan Kas
- data kapitalisasi buku:
Nilai Buku saben Saham Pulmatrix|PULM - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku pulmatrix.com|PULM - Nilai Agregat Aset
- data utang lan likuiditas:
Utang marang Ekuitas Pulmatrix, Inc.|PULM - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Pulmatrix, Inc.|PULM - Gunggung utang perusahaan|Utang marang nilai buku Pulmatrix|PULM - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Pulmatrix
Analisis komprehensif perusahaan:PULM - Pulmatrix
Produk merek Pulmatrix Corporation

The high scalability of Pulmatrix, Inc. (PULM) inhalation technologies requires significant funding for global market expansion. The historical trend of the total debt-to-equity ratio reflects the proportion of borrowed funds to net assets, allowing for an assessment of the financial leverage level and the impact of the weighted average cost of capital (WACC) on the overall balance sheet stability of Pulmatrix, Inc. (PULM) during periods of cyclical sector development.

Pesaing wigati

Utang marang Ekuitas Haleon HLN|Utang Agregat marang Ekuitas Kenvue Inc|Verona Pharma Corp (VRNA) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi Jyong Bio (MENS)|Total Utang marang Modal LGND (Ligand Pharmaceuticals)|amneal.com - Total Utang marang Modal|Utang marang Ekuitas Perrigo (PRGO)|ALVO: Rasio Kabeh Utang marang Dana Pribadi|LQDA (Liquidia Technologies) - Utang marang Ekuitas|Galapagos Corp (GLPG) - Rasio Total Utang marang Ekuitas|ANIP (ANI Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal mannkindcorp.com (MNKD)|Amphastar Pharmaceuticals, Inc. (AMPH) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi PCRX (Pacira Pharmaceuticals)|SPRY: Utang marang Ekuitas|TBPH - Utang marang Modal|Rasio Total Utang marang Ekuitas Aquestive Therapeutics AQST|SCPH - Utang Agregat marang Modal|Total Utang marang Modal tectonictx.com TECX|Tonix Pharma (TNXP) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal SXTC (SXT Pharmaceuticals)|Utang marang Modal EPRX|BioHarvest Sciences (BHST) - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi EXOZ (invizyne.com)|Oramed Pharmaceuticals Inc. (ORMP) - Utang marang Ekuitas|ENTX - Utang Agregat marang Ekuitas|MindWalk - Rasio Total Utang marang Ekuitas|ABVC: Total Utang marang Modal|Cumberland Pharmaceuticals (CPIX) - Utang marang Ekuitas|QNTM (quantumbiopharma.com) - Utang marang Ekuitas|Utang marang Ekuitas FGEN|Rasio Total Utang marang Ekuitas Telomir Pharmaceuticals Inc|Total Utang marang Modal RANI|Total Utang marang Modal synergychc.com SNYR|Rasio Total Utang marang Ekuitas Rallybio (RLYB)|Lexaria Bioscience Corp - Utang Agregat marang Modal|Utang marang Ekuitas Pheton (PTHL)|APM - Rasio Kabeh Utang marang Dana Pribadi|Lyra Therapeutics, Inc - Total Utang marang Modal|Koefisien Total Utang marang Modal Impact BioMedical, Inc.|Rasio Total Utang marang Ekuitas TNF Pharmaceuticals Inc. (TNFA)|Rasio Utang marang Ekuitas cbdMD Corp (YCBD)|PainReform (PRFX) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi altamiratherapeutics.com (CYTO)|Total Utang marang Modal LIPO|OptiNose Corp - Koefisien Total Utang marang Modal|Pieris Pharmaceuticals (PIRS) - Utang marang Ekuitas|PROC - Rasio Utang marang Ekuitas|PTPI (Petros Pharmaceuticals, Inc.) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Qilian International Holding Group|SLRN: Rasio Total Utang marang Ekuitas|Koefisien Total Utang marang Modal TFFP